Unknown

Dataset Information

Enhanced thromboprophylaxis in critically ill patients with COVID-19 infection.


ABSTRACT:

Background

Patients with severe SARS-CoV-2 infection have been shown to have abnormal coagulation parameters and are at increased risk of thromboembolism. The optimal thromboprophylaxis regimen that minimizes thrombosis without increased risk of serious bleeding is uncertain.

Objectives

To describe the efficacy and safety of increased intensity (enhanced) thromboprophylaxis in patients with COVID-19 admitted to the medical intensive care unit (MICU).

Methods

This is a retrospective cohort analysis of patients with a diagnosis of COVID-19 admitted to the MICU of an urban safety net hospital. With the exception of patients being supported with extracorporeal membrane oxygenation or on chronic anticoagulation who received therapeutic dosing of anticoagulation, thrombopro

SUBMITTER: Kummer RL 

PROVIDER: S-EPMC8019488 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature